Revance Therapeutics
RVNC
₹311.78
Share price
0.00%
Change (1 day)
-20.95%
Change (1 year)
Categories
EPS for Revance Therapeutics (RVNC)
EPS in 2023 (TTM): -₹372.35
According to Revance Therapeutics's latest financial reports the company's current EPS (TTM) is -₹386.95. In 2022 the company made an earnings per share (EPS) of -₹410.87 a decrease over its 2021 EPS that were of -₹357.06.
EPS history for Revance Therapeutics from 2013 to 2023
Annual EPS
| Year | EPS | Change |
|---|---|---|
| 2023 (TTM) | -₹372.35 | -9.37% |
| 2022 | -₹410.87 | 15.07% |
| 2021 | -₹357.06 | -13.81% |
| 2020 | -₹414.29 | 32.51% |
| 2019 | -₹312.64 | -7.11% |
| 2018 | -₹336.55 | -1.25% |
| 2017 | -₹340.83 | 25.47% |
| 2016 | -₹271.64 | 6% |
| 2015 | -₹256.26 | -21.47% |
| 2014 | -₹326.30 | 0.04% |
| 2013 | -₹326.16 |
EPS for similar companies or competitors
| Company | EPS | EPS differencediff. | Country |
|---|---|---|---|
 | -₹21.35 | -94.48% | 🇺🇸 USA |
 | ₹1,203 | -410.93% | 🇺🇸 USA |
 | ₹1,577 | -507.51% | 🇺🇸 USA |